CAS 82857-39-4

Formel: C17H22ClNO

InChl: InChI=1S/C17H21NO.ClH/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15;/h3-11,17-18H,12-13H2,1-2H3;1H/t17-;/m0./s1

InChI Key: LUCXVPAZUDVVBT-LMOVPXPDSA-N

SMILES: CC1=CC=CC=C1O[C@@H](CCNC)C2=CC=CC=C2.Cl

ATOMOXETINE IMPURITY B CRS

CAS: 82857-39-4

ATOMOXETINE IMPURITY B CRS

Formel: C₁₇H₂₁NO

Molekulargewicht: 255.3547

Ref: 41-Y0001588

Atomoxetine S-Isomer

CAS: 82857-39-4

Amino-alcohols, other than those containing more than o

Formel: C₁₇H₂₁NO·HCl

Farbe und Form: White Powder

Molekulargewicht: 255.16231

Ref: 45-1044913

1H,2H,3H,4H,9H-pyrido[3,4-b]indole-1,3-dicarboxylic acid

CAS: 82857-39-4

1H,2H,3H,4H,9H-pyrido[3,4-b]indole-1,3-dicarboxylic acid

Formel: C₁₃H₁₂N₂O₄

Reinheit: ≥98%

Molekulargewicht: 260.25

Ref: 54-BUP20331

Atomoxetine EP Impurity B HCl ((S)-Atomoxetine HCl)

CAS: 82857-39-4

Formel: C₁₇H₂₁NO·HCl

Molekulargewicht: 255.36 36.46

Ref: 4Z-A-2512

Atomoxetine EP Impurity B

CAS: 82857-39-4

Formel: C₁₇H₂₁NOHCl

Molekulargewicht: 255.4 : 36.46

Ref: ST-EA-CP-A30002

(+)-Tomoxetine hydrochloride

CAS: 82857-39-4

(+)-Tomoxetine hydrochloride is a bioactive chemical.

Formel: C₁₇H₂₂ClNO

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 291.82

Ref: TM-T21028

S-(+)-Atomoxetine Hydrochloride

Kontrolliertes Produkt

CAS: 82857-39-4

Impurity Atomoxetine EP Impurity B
Applications ent S-(+)-Atomoxetine Hydrochloride (Atomoxetine EP Impurity B) is an enatiomer of Atomoxetine, a Norepinephrine uptake blocker.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Robertson, D., et al.: J. Med. Chem., 31, 1412 (1988), Hwamg, et al.: Neurosci. Lett., 265, 151 (1999),

Formel: C₁₇H₂₁NO·ClH

Farbe und Form: Neat

Molekulargewicht: 291.82

Ref: TR-A791405

ent S-(+)-atomoxetine hydrochloride

Kontrolliertes Produkt

CAS: 82857-39-4

Ent S-Atomoxetine hydrochloride is a drug substance that is used for the preparation of atomoxetine hydrochloride. It is transferred to a suitable container, where it is validated with spectrophotometric measurements. The solution is then diluted and filtered using a phenomenex c18 column. The sample preparation involves the use of rp-hplc and photolytic methods, which can be scaled up to meet the needs of commercial production. Stability tests are performed on the drug substance before diluting it with a suitable solvent for storage, as well as in diluents for intravenous injection. Environment testing may also be required, depending on the formulation type. End>

Formel: C₁₇H₂₂ClNO

Reinheit: Min. 95%

Molekulargewicht: 291.82 g/mol

Ref: 3D-FE22676